SIGNED AWARD SPE2D2-23-D-0007 OLOPATADINE HCL 0.1% OPHTHALMIC SOLUTION.PDF
Published: 02/15/2023
Description
02/15/2023 Benjamin Hall, CEO 2/14/2023 02/15/2023 CONTRACT NO. SPE2D2-23-D-0007 Page 2 of 19 CONTINUED FROM PAGE 1 BLOCK 29 The following documents are hereby incorporated by reference into the contract award: Solicitation SPE2D2-22...
